Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database

Background: Sorafenib is approved for the targeted therapy of cancers such as liver cancer and renal cancer. Given its widespread use, drug-related adverse events have received attention, and the post-marketing regulatory link is crucial. Objective: By using the FAERS database to mine the adverse ev...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Lin Ning, Yuan Tian, Di Chen, Jie Han, Guanyue Xie, Jianguang Sun
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Subjects:	Sorafenib Cancer FAERS Adverse events Pharmacovigilance
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024133798